What is Novanta's other accrued liabilities?

Novanta (NOVT) reported other accrued liabilities of $66.6M in Q1 2026.

How has Novanta's other accrued liabilities changed year-over-year?

Novanta's other accrued liabilities increased by 18.3% year-over-year, from $56.29M to $66.6M.

What is the long-term trend for Novanta's other accrued liabilities?

Over 5 years (2020 to 2025), Novanta's other accrued liabilities has grown at a 3.4% compound annual growth rate (CAGR), from $53.78M to $63.5M.

Novanta NOVT Other accrued liabilities

Other accrued liabilities at other companies

CoherentCOHR

$332.79M+6.5%

Teradyne, Inc.TER

$122.51M+22.4%

Intuitive SurgicalISRG

——

Globus MedicalGMED

——

Regal RexnordRRX

——

Crane Co.CR

——

Other financials

Income statement

See full

Revenue$257.7M+10.4%

Gross profit$113.6M+8.8%

Operating income$27.5M-15.1%

Net income$21.1M-0.5%

EPS (diluted)$0.51-13.6%

Balance sheet

See full

Cash & equivalents$388.8M+267%

Total debt$291.3M-34.2%

Total equity$1.3B+70.3%

Total assets$1.8B+29.9%

Cash flow

See full

Operating cash flow$51.6M+62.9%

CapEx$4.1M-3.4%

Free cash flow$47.5M+73.2%

Valuation

See full

Market cap$5.53B-8.3%

Profitability

See full

Gross margin44.2%-0.5pp

Operating margin8.9%-3.5pp

Net margin5.3%-2.1pp

FCF margin6.8%-8.1pp

Returns & leverage

See full

Return on equity5.2%-4.6pp

Debt / equity0.2×-0.4×

Current ratio3.6×+1.0×

Where this comes from

Reported directly by Novanta in its filing.

Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.

The official record: Novanta’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novanta's other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Novanta's other accrued liabilities?: Novanta (NOVT) reported other accrued liabilities of $66.6M in Q1 2026.
How has Novanta's other accrued liabilities changed year-over-year?: Novanta's other accrued liabilities increased by 18.3% year-over-year, from $56.29M to $66.6M.
What is the long-term trend for Novanta's other accrued liabilities?: Over 5 years (2020 to 2025), Novanta's other accrued liabilities has grown at a 3.4% compound annual growth rate (CAGR), from $53.78M to $63.5M.